Precision Genome Engineering

精准基因组工程

基本信息

批准号：
10391367
负责人：
Thale Cross Jarvis
金额：
$ 2.22万
依托单位：
KEYSTONE SYMPOSIA
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-02-01 至 2023-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10391367
关键词：
Address Agricultural Development Benchmarking Biological Biology British Columbia CRISPR/Cas technology Canada Cell Therapy Cell model Cells Clustered Regularly Interspaced Short Palindromic Repeats Collaborations Data Development Disease Educational workshop Epigenetic Process Equilibrium Ethics Event Gender Gene Expression Genes Genome Genome engineering Genomic approach Genomics Hearing Joints Knowledge Learning Mentors Methodology Molecular Outcome Pain Participant Process Publications Publishing Research Research Personnel Science Scientist Stress Therapeutic Time Tissues Underrepresented Populations Update base biological research career catalyst clinical practice coronavirus disease design functional genomics genome editing innovation interest meetings new technology new therapeutic target next generation posters programs real world application success symposium therapy development tool translational scientist

项目摘要

ABSTRACT Support is requested for a Keystone Symposia conference entitled Precision Genome Engineering, organized by Drs. Jacob E. Corn, Kathy K. Niakan and Cecilia Cotta-Ramusino. The conference will be held in Whistler, British Columbia, Canada from February 13-17, 2022. Precision genome engineering has completely revolutionized biological research and is making groundbreaking inroads to therapies. Progress is rapid and the ability for researchers to meet and network is essential in order to stay updated with the latest advances in the field. This conference will focus on new fundamental CRISPR-Cas biology, creation of new genome engineering tools (both CRISPR-Cas and otherwise), provide updates on new biological applications, and discuss the latest advances on applications moving towards market, such as therapies and agricultural developments. The Keystone Symposia conference on CRISPR has been a benchmark of the field and draws large audiences. The continued development of creative new tools and further progress towards real-world application will be a big attraction for participants. This conference will also include workshops and panels on ethical questions that will enrich the scientific program. Finally, this meeting will be held jointly with the Keystone Symposia conference Emerging Cellular Therapies. This is an ideal pairing as genome engineering has become de rigueur in this arena. Genome engineer attendees will benefit by learning pain points and missing pieces in the field of cellular therapy, and cell therapy attendees will benefit by hearing about the latest breakthroughs in the fast- paced field of genome engineering.

抽象的请求支持Keystone研讨会会议，名为Precision Genome Engineering，有组织由Drs。 Jacob E. Corn，Kathy K. Niakan和Cecilia Cotta-Ramusino。会议将在惠斯勒举行加拿大不列颠哥伦比亚省，从2022年2月13日至17日。精密基因组工程已经完全彻底改变了生物学研究，并正在使对疗法的开创性进攻。进步很快，研究人员见面和网络的能力是为了保持最新进展，至关重要的是。这次会议将重点关注新的基本CRISPR-CAS生物学，创建新的基因组工程工具（CRISPR-CAS和否则），提供有关新生物应用的最新信息，并讨论应用程序的最新进展转向市场，例如治疗和农业发展。 Keystone专题讨论会 CRISPR会议一直是该领域的基准，吸引了大量观众。继续开发创造性的新工具并进一步发展对现实世界应用程序将是一个很大的吸引力对于参与者。这次会议还将包括有关将丰富的道德问题的研讨会和小组科学计划。最后，这次会议将与Keystone研讨会会议共同举行新兴的细胞疗法。这是一个理想的配对竞技场。基因组工程师的与会者将通过学习疼痛点和缺少碎片而受益细胞疗法和细胞疗法的参与者将通过听取快速的最新突破而受益基因组工程的节奏领域。